Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

946 ARTÍCULOS , VIENDO DEL 511 AL 525

The Evolution of AChE Inhibitors in Alzheimer's Disease: From Single-Target to Multi-Target Ligands

Mehta NV, Kapadia A, Khambete M, Abhyankar A.

Chembiochem. 2025 Sep 15;26(17):e202500053. doi: 10.1002/cbic.202500053. Epub 2025 Jul 28.

Asperuloside as a promising multi-target agent for Alzheimer's disease: molecular mechanisms and therapeutic perspectives

Vashisht K, Kumar H, Ankalgi A, Ashawat MS, Rimpi, Kushawaha SK, Baldi A.

Inflammopharmacology. 2025 Aug;33(8):4311-4321. doi: 10.1007/s10787-025-01869-w. Epub 2025 Jul 28.

The Therapeutic Potential of Butyrate and Lauric Acid in Modulating Glial and Neuronal Activity in Alzheimer's Disease

Senarath RMUS, Oikari LE, Bharadwaj P, Jayasena V, Martins RN, Fernando WMADB.

Nutrients. 2025 Jul 10;17(14):2286. doi: 10.3390/nu17142286.

The structural foundations of anti-amyloid-β immunotherapies: Unravelling antibody-antigen interactions in Alzheimer's disease treatment

Miles LA, Masters CL.

J Alzheimers Dis. 2025 Sep;107(2):393-408. doi: 10.1177/13872877251361049. Epub 2025 Sep 1.

Alzheimer's Disease: Treatment Challenges for the Future

Hardy J.

J Neurochem. 2025 Aug;169(8):e70176. doi: 10.1111/jnc.70176.

Application of Traditional Chinese Medicine in Alzheimer's Disease Treatment: A Focus on the Wnt/[Formula: see text]-Catenin Pathway

Ying C, He Y, Guo Y, Fan F, Wang B, Gao J, Li Y, Zhang Y.

Am J Chin Med. 2025;53(6):1641-1683. doi: 10.1142/S0192415X25500624. Epub 2025 Aug 1.

Resveratrol's Multifaceted Potential in Alzheimer's Disease: Insights from Preclinical and Clinical Evidence

Patel S, Thornton A, Parmar MS.

Mol Neurobiol. 2025 Dec;62(12):16229-16260. doi: 10.1007/s12035-025-05234-4. Epub 2025 Aug 1.

Mushrooms: Potential Agents for the Prevention and Slowdown of Alzheimer's Disease: A Review

Galić M, Ćilerdžić J, Stajic M.

Int J Med Mushrooms. 2025;27(10):7-19. doi: 10.1615/IntJMedMushrooms.2025059428.

Beyond epilepsy: The expanding role of valproic acid in Alzheimer disease therapy - a review

Markowicz-Piasecka M, Miłkowska Z, Adla SK, Huttunen KM, Pietrzak B.

J Pharmacol Exp Ther. 2025 Sep;392(9):103658. doi: 10.1016/j.jpet.2025.103658. Epub 2025 Jul 10.

Alzheimer's disease: Clinical trials to watch

Sabbagh MN, Kennedy J, Majeed J, Decourt B.

Med. 2025 Aug 8;6(8):100771. doi: 10.1016/j.medj.2025.100771.

The Therapeutic Potential of Glymphatic System Activity to Reduce the Pathogenic Accumulation of Cytotoxic Proteins in Alzheimer's Disease

Kopeć K, Koziorowski D, Szlufik S.

Int J Mol Sci. 2025 Aug 5;26(15):7552. doi: 10.3390/ijms26157552.

Neuroprotective Role of Omega-3 Fatty Acids: Fighting Alzheimer's Disease

Chávez-Castillo M, Gotera MP, Duran P, Díaz MP, Nava M, Cano C, Díaz-Camargo E, Cano G, Cano R, Rivera-Porras D, Bermúdez V.

Molecules. 2025 Jul 22;30(15):3057. doi: 10.3390/molecules30153057.

Engineered nanoplatforms for brain-targeted co-delivery of phytochemicals in Alzheimer's disease: Rational design, blood-brain barrier penetration, and multi-target therapeutic synergy

Chen L, Guan Y, Wang S, Han X, Guo F, Wang Y.

Neurotherapeutics. 2025 Oct;22(6):e00722. doi: 10.1016/j.neurot.2025.e00722. Epub 2025 Aug 14.

Mining Alzheimer's Interactomes, Macromolecular Complexes and Pathways for Drug Discovery

Panneerselvam K, Tiwari KK, Licata L, Panni S, Ricard-Blum S, Balu S, Huget S, Medina Reyes JJ, Ragueneau E, Perfetto L, Meldal B, Orchard S, Hermjakob H.

Proteomics. 2025 Nov;25(21-22):102-150. doi: 10.1002/pmic.70018. Epub 2025 Aug 25.

Role of Monoclonal Antibodies in Alzheimer's Disease: Successes, Failures, and Future Directions

Gupta A, Pahal S, Kumar V, Chaudhary A.

Neurol Sci. 2025 Nov;46(11):5607-5619. doi: 10.1007/s10072-025-08456-5. Epub 2025 Aug 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias